Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo, Japan.
Department of Molecular Pathology, National Cancer Center Hospital, Tokyo, Japan.
Ann Surg Oncol. 2024 Aug;31(8):4910-4921. doi: 10.1245/s10434-024-15313-w. Epub 2024 Apr 28.
Patients undergoing macroscopically curative resection for distal cholangiocarcinoma (DCC) have high recurrence rates and poor prognoses. This study aimed to investigate the impact of surgical margin status on survival and recurrence after resection of DCC, specifically focusing on microscopic residual tumor (R1) and its relationship to local recurrence.
This was a retrospective analysis of patients who had undergone pancreaticoduodenectomy (PD) for DCC between 2005 and 2021. Surgical margin was classified as R0, R1cis (positive bile duct margin with carcinoma in situ), and R1inv (positive bile duct margin with an invasive subepithelial component and/or positive radial margin).
In total, 29 of 133 patients (21.8%) had R1cis and 23 (17.3%) R1inv. The 5-year overall survival (OS) for R0 (55.7%) did not differ significantly from that for R1cis/R1inv (47.4%/33.6%, respectively). The 5-year recurrence-free survival (RFS) for R0 was significantly longer than that for R1inv (50.1% vs. 17.4%, p = 0.003), whereas RFS did not differ significantly between those with R0 and R1cis. R1cis/R1inv status was not an independent predictor of OS and RFS in multivariate analysis. Cumulative incidence of isolated distant recurrence was significantly higher for R1cis/R1inv than for R0 (p = 0.0343/p = 0.0226, respectively), whereas surgical margin status was not significantly associated with rates of local or local plus distant recurrence.
Surgical margin status does not significantly impact OS and RFS in patients undergoing PD for DCC following precise preoperative imaging evaluation. Additionally, R1 status is significantly linked to higher isolated distant recurrence rather than local recurrence, highlighting the importance of multidisciplinary therapy.
接受远端胆管癌(DCC)根治性切除术的患者复发率和预后较差。本研究旨在探讨手术切缘状态对 DCC 切除后生存和复发的影响,特别是关注显微镜下残留肿瘤(R1)及其与局部复发的关系。
这是一项对 2005 年至 2021 年间接受胰十二指肠切除术(PD)治疗 DCC 的患者进行的回顾性分析。手术切缘分为 R0、R1cis(阳性胆管切缘伴原位癌)和 R1inv(阳性胆管切缘伴上皮下侵袭性成分和/或阳性放射状切缘)。
共有 133 例患者中的 29 例(21.8%)为 R1cis,23 例(17.3%)为 R1inv。R0 组(55.7%)的 5 年总生存率(OS)与 R1cis/R1inv 组(分别为 47.4%/33.6%)无显著差异。R0 组的 5 年无复发生存率(RFS)明显长于 R1inv 组(50.1%比 17.4%,p=0.003),而 R0 与 R1cis 组之间的 RFS 无显著差异。多因素分析显示,R1cis/R1inv 状态不是 OS 和 RFS 的独立预测因素。孤立远处复发的累积发生率 R1cis/R1inv 明显高于 R0(p=0.0343/p=0.0226),而手术切缘状态与局部或局部加远处复发率无显著相关性。
经过精确的术前影像学评估,PD 治疗 DCC 后,手术切缘状态对患者的 OS 和 RFS 无显著影响。此外,R1 状态与较高的孤立远处复发率显著相关,而与局部复发率无关,这突出了多学科治疗的重要性。